AnGes Inc
OTC:AMGXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AnGes Inc
OTC:AMGXF
|
JP |
|
Cellectar Biosciences Inc
NASDAQ:CLRB
|
US |
|
Lakeland Industries Inc
NASDAQ:LAKE
|
US |
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
H
|
Hanza AB
STO:HANZA
|
SE |
|
Canandaigua National Corp
OTC:CNND
|
US |
|
Meiji Holdings Co Ltd
OTC:MEJHY
|
JP |
|
Kadoya Sesame Mills Inc
TSE:2612
|
JP |
|
H
|
Heiq PLC
LSE:HEIQ
|
UK |
|
ANZ Group Holdings Ltd
OTC:ANZGY
|
AU |
|
Ibersol SGPS SA
LSE:0KJ7
|
PT |
|
Brouwerij - Handelsmaatschappij NV
XBRU:COBH
|
BE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMGXF's stock price target?
Not Available
AMGXF doesn't have any price targets made by Wall Street professionals.
What is AnGes Inc's Revenue forecast?
Projected CAGR
-6%
For the last 14 years the
compound annual growth rate for
AnGes Inc's revenue is
10%.
The projected
CAGR
for the next 10 years is
-6%.